Validation pour Ingenuity236

vers la météo de la validation par utilisateur

Ingenuity236

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 12 - PMID ?

In Hela cells treated with agonist anti SP Apo 1 [NODE] protein antibody and overproducing SP NODE protein , SP NODE protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a NODE protein protein binding site .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
      +-------------COMP:V-N(In)------------+                                                                          +---------------APPOS--------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
      |    +------------SUBJ:V-N------------+                                +-------------SUBJ:V-N------------+       |         +------MOD_ATT:N-ADJ-----+                                         +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +COMP:V_PASS-N(with)+     |              +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+       |         |       +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +OBJ:+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+         |       |       +MOD_ATT:+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,Apo)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__SP__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 1

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
      +-------------COMP:V-N(In)------------+                                                                                                                                                                                                                           |        +---------MOD_ATT:N-ADJ--------+   
      |    +------------SUBJ:V-N------------+                                                                                                                                                       +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +COMP:V_PASS-N(with)+     |              +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       +------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +OBJ:+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,Apo)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 2

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                  +------------OBJ:V-N-----------+                                                                                                                                                                                                                      |        +---------MOD_ATT:N-ADJ--------+   
                  +------COMP:V-N(with)-----+    |                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+                 +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 3

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
      +-------------COMP:V-N(In)------------+                                                                                                                                                       +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +------------SUBJ:V-N------------+                                                                                                             +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +COMP:V_PASS-+            |              +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      +---OBJ:V-N--+     +OBJ:+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,anti)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,Apo)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 4

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
      +-------------COMP:V-N(In)------------+                                                                                                                                                                                                                           |        +---------MOD_ATT:N-ADJ--------+   
      |    +------------SUBJ:V-N------------+                                                                                                             +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +------COMP:N-N(with)------+     |              +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+                 +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +OBJ:+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,anti)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,Apo)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 5

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                    +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                                                                  +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+            +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       +------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 6

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +--------COMP:V-N(with)--------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+                 +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 7

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+            +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+                 +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 8

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       +------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+          |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |          |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 9

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       +------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 10

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                    +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 11

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
      +-------------COMP:V-N(In)------------+                                                                                                                                                                                                                           |        +---------MOD_ATT:N-ADJ--------+   
      |    +------------SUBJ:V-N------------+                                                                                                             +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +COMP:V_PASS-+            |              +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      +---OBJ:V-N--+     +OBJ:+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,anti)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,Apo)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 12

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                  +------COMP:V-N(with)-----+                                                                                                                                                       +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                  |      +--------OBJ:V-N--------+                                                                                                                                                  +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 13

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                       +---------------APPOS--------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
                         +--------OBJ:V-N--------+                                                                     |         +------MOD_ATT:N-ADJ-----+                                         +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       |         |       +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |       |       +MOD_ATT:+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__SP__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 14

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                    +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                                                                                                                                                                    +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+                 +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 15

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       +------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 16

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                       +---------------APPOS--------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
                         +--------OBJ:V-N--------+                                                                     |         +------MOD_ATT:N-ADJ-----+                                         +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       |         |       +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |       |       +MOD_ATT:+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__SP__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 17

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                       +---------------APPOS--------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
                         +--------OBJ:V-N--------+                                                                     |         +------MOD_ATT:N-ADJ-----+                                         +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       |         |       +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |       |       +MOD_ATT:+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__SP__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 18

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                  +------------OBJ:V-N-----------+                                                                                                                                                  +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                  +---COMP:V-N(with)--+          |                           +-------------SUBJ:V-N------------+                                          +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      +------OBJ:V-N-----+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+                 +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      |     +MOD_AT+     |    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
OBJ:V-N (with,__SP__)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 19

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                    +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                                                                  +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      +------OBJ:V-N-----+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,Apo)
OBJ:V-N (with,__SP__)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 20

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                       +---------------APPOS--------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                     |         +------MOD_ATT:N-ADJ-----+                                         +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+            +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       |         |       +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |       |       +MOD_ATT:+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__SP__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 21

                                                                                                               +------------------OBJ:V-N-----------------+                                                                                                             +----------------OBJ:V-N----------------+   
                  +------------OBJ:V-N-----------+                                                             |       +-------------SUBJ:V-N-------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
                  +------COMP:V-N(with)-----+    |                                                             |       +----------APPOS----------+        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+       |       |         +-MOD_ATT:N-ADJ-+        |              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+OBJ:V-N+       |         |       +MOD_ATT+        |              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 22

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                       +---------------APPOS--------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
                                                                                                                       |         +------MOD_ATT:N-ADJ-----+                                         +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+         |       +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+         |       |       +MOD_ATT:+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__SP__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 23

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                       +---------------APPOS--------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                     |         +------MOD_ATT:N-ADJ-----+                                         +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+         |       +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+         |       |       +MOD_ATT:+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__SP__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 24

                                                                                                               +------------------OBJ:V-N-----------------+                                                                                                             +----------------OBJ:V-N----------------+   
                  +------COMP:V-N(with)-----+                                                                  |       +-------------SUBJ:V-N-------------+                                         +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                  |      +--------OBJ:V-N--------+                                                             |       +----------APPOS----------+        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+       |       |         +-MOD_ATT:N-ADJ-+        |              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+OBJ:V-N+       |         |       +MOD_ATT+        |              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 25

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+         +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 26

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       +------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+          |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |          |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 27

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                           +-------------SUBJ:V-N------------+                                          +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+       +------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 28

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+                 +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 29

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                       +---------------APPOS--------------+                                         +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                           +-------------SUBJ:V-N------------+       |         +------MOD_ATT:N-ADJ-----+                                         +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+COMP:V-N(wit+                 |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+       |         |       +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      +---OBJ:V-N--+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+         |       |       +MOD_ATT:+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,Apo)
OBJ:V-N (with,anti)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__SP__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 30

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                                                                  +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+            +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+         +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 31

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                    +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+         +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 32

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                    +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                                                                                                                                                                    +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+         +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 33

                                                                                                               +------------------OBJ:V-N-----------------+                                                                                                             +----------------OBJ:V-N----------------+   
                                                                                                               |       +-------------SUBJ:V-N-------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
                  +--------COMP:V-N(with)--------+                                                             |       +----------APPOS----------+        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+       |       |         +-MOD_ATT:N-ADJ-+        |              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+OBJ:V-N+       |         |       +MOD_ATT+        |              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 34

                                                                                                               +------------------OBJ:V-N-----------------+                                                                                                             +----------------OBJ:V-N----------------+   
      +-------------COMP:V-N(In)------------+                                                                  |       +-------------SUBJ:V-N-------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
      |    +------------SUBJ:V-N------------+                                                                  |       +----------APPOS----------+        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +------COMP:N-N(with)------+     |              +---MOD_ATT:N-N---+---------SUBJ:V-N--------+       |       |         +-MOD_ATT:N-ADJ-+        |              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     +OBJ:+         |        +MOD_ATT:+              +-SUBJ:V-N-+OBJ:V-N+       |         |       +MOD_ATT+        |              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |            |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,anti)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,Apo)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 35

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
      +-------------COMP:V-N(In)------------+                                                                                                                                                       +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +------------SUBJ:V-N------------+                                                                                                                                                       +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +COMP:V_PASS-+            |              +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      +---OBJ:V-N--+     +OBJ:+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,anti)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,Apo)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 36

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                    +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                                                                                                                                                                    +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       +------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 37

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+COMP:V-N(wit+                 |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+       +------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      +---OBJ:V-N--+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,Apo)
OBJ:V-N (with,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 38

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                         +--------OBJ:V-N--------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+         +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 39

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                         +--------OBJ:V-N--------+                                                                                                                                                  +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+         +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 40

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                                                                                                                                                                                                                                        |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                                                                        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+COMP:V-N(wit+                 |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+         +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      +---OBJ:V-N--+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,Apo)
OBJ:V-N (with,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 41

                                                                                                               +------------------OBJ:V-N-----------------+                                                                                                             +----------------OBJ:V-N----------------+   
                                                                                                               |       +-------------SUBJ:V-N-------------+                                                                                                             |        +---------MOD_ATT:N-ADJ--------+   
                  +------------OBJ:V-N-----------+                                                             |       +----------APPOS----------+        +---------COMP:V-N(in)---------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+COMP:V-N(wit+                 |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+       |       |         +-MOD_ATT:N-ADJ-+        |              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+      +---OBJ:V-N--+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+OBJ:V-N+       |         |       +MOD_ATT+        |              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |     |      |     |    |         |        |        |              |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,Apo)
OBJ:V-N (with,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 42

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
      +-------------COMP:V-N(In)------------+----------------------------------OBJ:V-N---------------------------------+                                                                                                                                                |        +---------MOD_ATT:N-ADJ--------+   
      |    +------------SUBJ:V-N------------+--------OBJ:V-N--------+                       +-------MOD_ATT:N-ADJ------+                                                                            +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +COMP:V_PASS-N(with)+     |       +--MOD_ATT:N-N--+                       |          +-MOD_ATT:N-ADJ-+         +---------OBJ:V-N--------+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     |       |      +MOD_ATT:+                       |          |       +MOD_ATT+--APPOS--+       +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |       |      |        |                       |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 43

                                                                                                                                                                                                                                                                        +----------------OBJ:V-N----------------+   
      +-------------COMP:V-N(In)------------+----------------------------------OBJ:V-N---------------------------------+                                                                                                                                                |        +---------MOD_ATT:N-ADJ--------+   
      |    +------------SUBJ:V-N------------+--------OBJ:V-N--------+                       +-------MOD_ATT:N-ADJ------+                                                                            +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +COMP:V_PASS-N(with)+     |       +--MOD_ATT:N-N--+                       |          +-MOD_ATT:N-ADJ-+------APPOS------+-----OBJ:V-N----+              +--MOD_ATT:N-N--+          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+            +MOD_AT+     |       |      +MOD_ATT:+                       |          |       +MOD_ATT+         +MOD_ATT+       +SUBJ:V-N+              |      +MOD_ATT:+          |               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |            |      |     |       |      |        |                       |          |       |       |         |       |       |        |              |      |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein , __SP__ __NODE__ protein decreases ( in a dose dependent manner ) activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)